Panelists discuss how the SUNLIGHT trial’s demonstration that adding bevacizumab to trifluridine/tipiracil improves overall survival and progression-free survival represents the…
A panelist discusses how financial burdens and insurance limitations impact chronic myeloid leukemia treatment decisions, with newer drugs like asciminib…